Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial. (Q40481513)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial. |
scientific article |
Statements
1 reference
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial. (English)
1 reference
Chloe Orkin
1 reference
Jürgen K Rockstroh
1 reference
Michael S Saag
1 reference
Mark Sulkowski
1 reference
Jay Lalezari
1 reference
Mark Nelson
1 reference
Josep Mallolas
1 reference
Mark Bloch
1 reference
Gail V Matthews
1 reference
Philippe J Zamor
1 reference
Jacqueline Gress
1 reference
Stephanie Klopfer
1 reference
Melissa Shaughnessy
1 reference
Janice Wahl
1 reference
Bach-Yen T Nguyen
1 reference
Eliav Barr
1 reference
Heather L Platt
1 reference
Michael N Robertson
1 reference
9 July 2015
1 reference
1 reference
2
1 reference
8
1 reference
e319-27
1 reference
Identifiers
1 reference
1 reference